CD4 and myasthenia gravis: To evaluate whether the effect of melatonin on CD4+ T cells involves a change in cell viability, we analyzed potential differences in the proliferation and viability of melatonin- or vehicle-treated CD4+ T cells from both HCs and MG patients.